کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2754191 1149758 2006 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Atypical CD8+ Cutaneous T-Cell Lymphoma After Immunomodulatory Therapy
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی بیهوشی و پزشکی درد
پیش نمایش صفحه اول مقاله
Atypical CD8+ Cutaneous T-Cell Lymphoma After Immunomodulatory Therapy
چکیده انگلیسی

Systemic immunomodulatory agents have recently been approved for the treatment of rheumatoid arthritis and psoriasis. Although lymphomas are known to emerge in the setting of immunosuppressive therapy, it has not been well described or established for the newer biologic immune response modifiers. Herein, we describe 2 patients who developed unusual CD8+ cutaneous lymphoproliferative disorders after treatment with efalizumab and infliximab. The mechanisms and occurrence of lymphoma after immune response modifiers are discussed.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Lymphoma and Myeloma - Volume 6, Issue 4, January 2006, Pages 329-332